Company
Our Solution
News
Contact us
Browse by category:
All
Insight
Apr 8, 2026
Immuvera Therapeutics Attended AHNTI Europe 2026 in London
Jan 15, 2026
Successful capital raise paves the way for pet cancer treatment
Sep 26, 2025
Immuvera Therapeutics receives EMA Limited Market Authorisation and advances to registration study
